Sustained Increases in Cardiomyocyte Protein O -Linked β-N-Acetylglucosamine Levels Lead to Cardiac Hypertrophy and Reduced Mitochondrial Function Without Systolic Contractile Impairment.
Chae-Myeong HaSayan BakshiManoja K BrahmaLuke A PotterSamuel F ChangZhihuan SunGloria A BenavidesLihao HePrachi UmbarkarLuyun ZouSamuel CurfmanSini SunnyAndrew J PatersonNamakkal-Soorappan RajasekaranJarrod W BarnesJianhua ZhangHind LalMin XieVictor M Darley-UsmarJohn C ChathamAdam R WendePublished in: Journal of the American Heart Association (2023)
Background Lifestyle and metabolic diseases influence the severity and pathogenesis of cardiovascular disease through numerous mechanisms, including regulation via posttranslational modifications. A specific posttranslational modification, the addition of O -linked β- N acetylglucosamine ( O -GlcNAcylation), has been implicated in molecular mechanisms of both physiological and pathologic adaptations. The current study aimed to test the hypothesis that in cardiomyocytes, sustained protein O -GlcNAcylation contributes to cardiac adaptations, and its progression to pathophysiology. Methods and Results Using a naturally occurring dominant-negative O -GlcNAcase (dnOGA) inducible cardiomyocyte-specific overexpression transgenic mouse model, we induced dnOGA in 8- to 10-week-old mouse hearts. We examined the effects of 2-week and 24-week dnOGA overexpression, which progressed to a 1.8-fold increase in protein O- GlcNAcylation. Two-week increases in protein O -GlcNAc levels did not alter heart weight or function; however, 24-week increases in protein O -GlcNAcylation led to cardiac hypertrophy, mitochondrial dysfunction, fibrosis, and diastolic dysfunction. Interestingly, systolic function was maintained in 24-week dnOGA overexpression, despite several changes in gene expression associated with cardiovascular disease. Specifically, mRNA-sequencing analysis revealed several gene signatures, including reduction of mitochondrial oxidative phosphorylation, fatty acid, and glucose metabolism pathways, and antioxidant response pathways after 24-week dnOGA overexpression. Conclusions This study indicates that moderate increases in cardiomyocyte protein O -GlcNAcylation leads to a differential response with an initial reduction of metabolic pathways (2-week), which leads to cardiac remodeling (24-week). Moreover, the mouse model showed evidence of diastolic dysfunction consistent with a heart failure with preserved ejection fraction. These findings provide insight into the adaptive versus maladaptive responses to increased O- GlcNAcylation in heart.
Keyphrases
- cardiovascular disease
- left ventricular
- mouse model
- gene expression
- protein protein
- blood pressure
- heart failure
- oxidative stress
- placebo controlled
- binding protein
- cell proliferation
- high glucose
- amino acid
- transcription factor
- physical activity
- type diabetes
- metabolic syndrome
- small molecule
- high intensity
- fatty acid
- randomized controlled trial
- body mass index
- single cell
- endothelial cells
- squamous cell carcinoma
- neoadjuvant chemotherapy
- lymph node
- radiation therapy
- copy number
- cardiovascular events
- smooth muscle